Jubilant Ingrevia receives USFDA EIR for Baruch facility Ruchika Sharma28 Jun 2024 12:30 PM ISTNoida: Jubilant Ingrevia Limited has announced successful outcome of the USFDA inspection with the receipt of Establishment Inspection report...
Aurobindo Pharma arm Telangana injectable unit gets USFDA VAI classification Ruchika Sharma27 Jun 2024 3:03 PM ISTTelangana: Aurobindo Pharma has informed in a BSE filing that the injectable facility of Eugia SEZ Pvt. Ltd., a 100 per cent step-down subsidiary...
USFDA concludes inspection at Shilpa Medicare Hyderabad unit with zero observations Ruchika Sharma26 Jun 2024 1:30 PM ISTKarnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has concluded the inspection at the Company's Bio...
Cipla Patalganga facility gets VAI classification from USFDA Ruchika Sharma26 Jun 2024 12:30 PM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
USFDA issues EIR for Alkem Labs Baddi facility Ruchika Sharma25 Jun 2024 4:48 PM ISTMumbai: Alkem Labs has informed in a BSE filing that the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report...
American lawmakers question FDAs drug inspection programme in India, China Ruchika Sharma25 Jun 2024 12:30 PM ISTWashington: Three prominent American lawmakers have questioned the Food and Drug Administration's foreign drug inspection program in India and...
USFDA inspection: Biocon gets 4 observations for Visakhapatnam API facility Ruchika Sharma24 Jun 2024 2:15 PM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded a GMP inspection of the...
USFDA issues EIR for Lupin Somerset facility Ruchika Sharma24 Jun 2024 11:18 AM ISTMumbai: Global pharma major Lupin Limited today announced that it has received the Establishment Inspection Report (EIR) from the United States...
Cipla Goa facility gets 6 USFDA observations Ruchika Sharma22 Jun 2024 3:31 PM ISTMumbai: Pharma major, Cipla, has received six inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) after...
USFDA issues warning letter to Sun Pharma Dadra facility Ruchika Sharma20 Jun 2024 12:34 PM ISTMumbai: Sun Pharmaceutical Industries Limited has received a Warning Letter from the US Food and Drug Administration (USFDA) for its Dadra...
USFDA issues 3 observations for Biocon Visakhapatnam API facility Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Lupin Nagpur Injectable facility concludes USFDA inspection with zero 483 observations Ruchika Sharma14 Jun 2024 12:33 PM ISTMumbai: Global pharma major Lupin Limited today announced that the United States Food and Drug Administration (U.S. FDA) has completed an...
